Multicenter Evaluation of BioFire FilmArray Meningitis/Encephalitis Panel for Detection of Bacteria, Viruses, and Yeast in Cerebrospinal Fluid Specimens
Open accessThe DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index; 16 of the 54 sources its claims cite were checked for support.
Abstract
Multicenter evaluation of 1,560 prospectively collected CSF specimens showing high agreement for multiple targets on the BioFire ME panel.
Overview
CoChat Summary
TL;DR
The FilmArray ME Panel rapidly detects 14 pathogens directly from CSF with high specificity and mostly high sensitivity in a multicenter evaluation of 1,560 prospectively collected specimens. Sensitivity/PPA was 100% for 9 of 14 analytes, with lower values for enterovirus (95.7%) and HHV-6 (85.7%), and no detections of *L. monocytogenes* or *N. meningitidis*.
Key findings
- Among 1,560 CSF specimens, FilmArray detected at least one pathogen in 136 (8.7%); the most prevalent targets were enterovirus (51/136, 37.5%), HHV-6 (22/136, 16.2%), *S. pneumoniae* (16/136, 11.8%), HSV-2 (12/136, 8.8%), and HPeV (12/136, 8.8%).
- Sensitivity/PPA was 100% for 9 of 14 analytes; enterovirus was 95.7% (44/46) and HHV-6 was 85.7% (18/21). *L. monocytogenes* and *N. meningitidis* were not detected by FilmArray or culture, so sensitivity could not be calculated.
- For *S. agalactiae*, there was one false-positive and one false-negative result, giving sensitivity 0% and specificity 99.9%. Specificity/NPA was ≥99.2% for all analytes, and overall agreement between FilmArray and comparator testing was 99.8% (21,791/21,840).
- The investigational-use-only EBV target had PPA 81.8% and NPA 98.5% and was excluded from the final commercial ME Panel.
Methods
- Multicenter prospective evaluation at 11 geographically distinct U.S. sites from February through September 2014; residual CSF specimens collected by lumbar puncture with ≥500 μl uncentrifuged CSF, enrolled within 7 days, and repeat specimens excluded. Of 1,643 acquired specimens, 83 were excluded, leaving 1,560 in the final analysis.
- FilmArray ME Panel testing used approximately 200 μl of CSF with automated nucleic acid extraction, reverse transcription, amplification, and analysis in approximately 1 h. Comparator methods were bacterial culture for bacterial analytes and PCR plus bidirectional sequencing for viral and yeast analytes; discrepant results were investigated, but reported performance used unresolved data only.
- Sensitivity/PPA was calculated as 100 × [TP/(TP + FN)] and specificity/NPA as 100 × [TN/(TN + FP)], with exact binomial two-sided 95% confidence intervals by the Wilson score method.
Limitations
- Stated: clinical data were analyzed retrospectively; full clinical data were not available for all patients; records for readmissions, follow-up treatment, or additional testing after LP were not accessible; standard CSF testing differed across sites and could affect discrepancy investigation; pretest probability for infectious ME was not controlled because enrollment was based on CSF culture submission with sufficient residual volume.
- Stated: there were 22 unresolved false-positive results, with possible contamination during aliquoting/testing or from oral flora/operator; the panel does not provide antibiotic susceptibility information and does not cover all bacterial CNS pathogens, so culture and Gram stain remain necessary.
- Evident from the text: low prevalence of many targets yielded few positive detections and wide or incalculable confidence intervals for several analytes, limiting precision of performance estimates.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 24 Not checked · 141 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This leads to delays, which can have significant clinical consequences if therapy is delayed or incorrectly administered (9–11).”
What the sources say
- Partly supportedcites [9] Shah SS, Aronson PL, Mohamad Z, Lorch SA. 2011. Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics 128:1153–1160. doi: 10.1542/peds.2011-0177. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Outcome Measures passage reports that death rates rose with each additional day before acyclovir treatment began in neonates with HSV infection. The paper does not establish that delays in CSF testing caused treatment delays, and it does not examine incorrectly administered therapy as an outcome. No page numbers are available in our copy. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [10] Barquet N, Domingo P, Cayla JA, Gonzalez J, Rodrigo C, Fernandez-Viladrich P, Moraga-Llop FA, Marco F, Vazquez J, Saez-Nieto JA, Casal J, Canela J, Foz M. 1997. Prognostic factors in meningococcal disease. Development of a bedside predictive model and scoring system. Barcelona Meningococcal Disease Surveillance Group. JAMA 278:491–496. [DOI] [PubMed] [Google Scholar] source
- Partly supportedcites [11] Cartwright K, Reilly S, White D, Stuart J. 1992. Early treatment with parenteral penicillin in meningococcal disease. BMJ 305:143–147. doi: 10.1136/bmj.305.6846.143. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The Introduction links diagnostic or therapeutic delay in meningococcal disease to higher mortality, and the section on antibiotics before admission warns that delaying treatment to confirm a diagnosis can be fatal. The paper does not establish that delays in CSF testing cause treatment delays, or that incorrectly administered therapy has the stated clinical consequences. The indexed passages provide section labels but no page numbers. (LLM, conf=0.86)
plainstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“It has been shown that cryptococcal antigen can remain positive for long periods of time after therapy, even when culture and smears are negative (40).”
What the sources say
- Supportedcites [40] Lu H, Zhou Y, Yin Y, Pan X, Weng X. 2005. Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital. J Clin Microbiol 43:2989–2990. doi: 10.1128/JCM.43.6.2989-2990.2005. [DOI] [PMC free article] [PubMed] [Google Scholar] source
The paper reports that cryptococcal antigen remained detectable for months after successful therapy. Its results also state that antigen remained detectable when both fungal stain and culture had turned negative. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The definitive diagnosis of bacterial meningitis has been historically based on isolation in culture, which has a sensitivity of, on average, approximately 80% or greater (1).”
What the sources say
- Could not verifycites [1] Brouwer MC, Tunkel AR, van de Beek D. 2010. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev 23:467–492. doi: 10.1128/CMR.00070-09. [DOI] [PMC free article] [PubMed] [Google Scholar] sourceExperimental — accuracy not yet measured
The table of contents lists a “CSF Cultures” section on p. 475, but its text is absent from our truncated copy. The Introduction reports that bacteria could not be cultured in 33% of cases in one Brazilian case series; that does not establish an average culture sensitivity or the historical basis of definitive diagnosis. Searches for CSF culture sensitivity and the approximately 80% figure did not find a passage that settles the claim. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The FilmArray ME Panel demonstrated a sensitivity or positive percentage of agreement of 100% for 9 of 14 analytes.”
boostedn = 1,560- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“All other assay targets were detected in 7 (5%) or fewer of the specimens.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims
Create a free account to see all 178 claims and to verify the 2 references still open.
- Probably not a substantial claim. 64
- It may state two separate claims as one. 78
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Overall accuracy between gold standard testing and the ME panel is reported between 93 and 99% (15–23).”
From Clinical Utilization of the FilmArray Meningitis/Encephalitis (ME) Multiplex Polymerase Chain Reaction (PCR) Assay (2019) · cites this paper as [17]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Causes of FP are related to sample contamination and cross-reactivity with other bacteria.8,10”
From Biofire FilmArray Meningitis/Encephalitis panel for the aetiological diagnosis of central nervous system infections: A systematic review and diagnostic test accuracy meta-analysis (2022) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Timely and accurate diagnosis of CNS infections is essential to avoid unnecessary antimicrobial therapy, reduce diagnostic uncertainty, limit hospital stay, and ultimately prevent morbidity and mortality.10,11”
From Utility and clinical relevance of multiplex PCR panels for diagnosis of central nervous system infections (2026) · cites this paper as [10]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, CSF ME panel is not recommended to be performed in the CSF from shunt as it does not include Staphylococcus species, coagulase-negative staphylococci, Cutibacterium acnes, or Corynebacterium species, which are common causes of shunt infection [11].”
From Clinical utility of a cerebrospinal fluid multiplex PCR meningitis/encephalitis panel in children: a retrospective review of positive results (2026) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have demonstrated the accuracy and clinical utility of FA-M/E in adults from North America and some European countries (5–8).”
From Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study (2024) · cites this paper as [7]
Experimental — accuracy not yet measured
35 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“The resulting performance characteristics were a PPA of 81.8% (95% CI, 61.5 to 92.7) with two false-negative results”
Reported 2 · recomputed 4
Citations
Cites
Kaper, J. B., Nataro, J. P., & Mobley, H. L. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro818 · Cited by 5,583 · cited 13×
“They are critical pathogens in certain populations, including immunosuppressed patients (34), and are best detected in the CNS by molecular methods (23).”
BackgroundInfluentialTwo-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Clinical features and prognostic factors in adults with bacterial meningitis
van de Beek, D., de Gans, J., Spanjaard, L., Weisfelt, M., Reitsma, J. B., & Vermeulen, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040845 · Cited by 1,639
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Acute Bacterial Meningitis in Adults -- A Review of 493 Episodes
Durand, M. L., Calderwood, S. B., Weber, D. J., Miller, S. I., Southwick, F. S., Caviness, V. S., & Swartz, M. N. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301073280104 · Cited by 1,344 · cited 1×
“While pleocytosis in the CSF is a sensitive marker of inflammation, several studies have shown cell counts may be normal in both adult and pediatric patients despite a diagnosis of bacterial meningitis (21, 22).”
BackgroundBacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Bacterial Meningitis in the United States, 1998–2007
Thigpen, M. C., Whitney, C. G., Messonnier, N. E., Zell, E. R., Lynfield, R., Hadler, J. L., Harrison, L. H., Farley, M. M., Reingold, A., Bennett, N. M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1005384 · Cited by 953
Epidemiology, Diagnosis, and Antimicrobial Treatment of Acute Bacterial Meningitis
Brouwer, M. C., Tunkel, A. R., & van de Beek, D. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00070-09 · Cited by 930 · cited 3×
“Gram stain has been assessed in cases of suspected meningitis and reported to have sensitivity ranging from 10 to 93%, depending on the organism and population being tested (1), and a near 100% specificity (21).”
BackgroundEdmond, K., Clark, A., Korczak, V. S., Sanderson, C., Griffiths, U. K., & Rudan, I. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70048-7 · Cited by 631 · cited 1×
“Those surviving infection may have significant long-term sequelae, such as loss of limbs, problems with vision and hearing, seizures, and cognitive deficits (2).”
BackgroundBuss, S. N., Leber, A., Chapin, K., Fey, P. D., Bankowski, M. J., Jones, M. K., Rogatcheva, M., Kanack, K. J., & Bourzac, K. M. (2015) · Journal of Clinical Microbiology · doi:10.1128/jcm.02674-14 · Cited by 554 · cited 1×
“38%]) is consistent with other published data on different FilmArray panels and indicates there was not a significant amount of inhibition of PCR in the samples (15).”
ResultSelf-citation
Research works printed but not linked: 1
- BioFire Diagnostics. 2015. FilmArray Meningitis/Encephalitis (ME) Panel instruction booklet RF-Y-ASY-0118. BioFire Diagnostics, Salt Lake City, UT. [Google Scholar]
Cited by
Items 201–300 of 617
Li, X., Yang, L., Li, D., Yang, X., Wang, Z., Chen, M., Wu, F., Dou, X., Niu, M., Qi, H., et al. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.02530-22 · Cited by 21
“sample volumes and low detection efficiency (32) hinder the comprehensive detection of such pathogens using conventional methods.”
MethodConsolidation of molecular testing in clinical virology
Scagnolari, C., Turriziani, O., Monteleone, K., Pierangeli, A., & Antonelli, G. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2017.1271711 · Cited by 16
Vector-Borne Disease is a Common Cause of Hospitalized Febrile Illness in India
Robinson, M. L., Kadam, D., Khadse, S., Balasubramanian, U., Raichur, P., Valvi, C., Marbaniang, I., Kanade, S., Sachs, J. W., Basavaraj, A., et al. (2018) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.17-0571 · Cited by 15
To LP or not to LP? Identifying the Etiology of Pediatric Meningitis
Mijović, H., & Sadarangani, M. (2019) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000002313 · Cited by 18
“The FilmArray Multiplex ME Panel (BioFire, Salt Lake City, Utah, USA) can simultaneously detect and identify five bacterial, seven viral, and two fungal common meningoencephalitis pathogens and takes about an hour to perform.(40) It is currently the only US Food and Drug Administration approved multiplex panel for CSF…”
BackgroundAcuña, M., Dona Benadof, F., Yohannessen, K., V, Leiva, Y., & Clement, P. (2022) · BMC Pediatrics · doi:10.1186/s12887-022-03241-1 · Cited by 15
Ekambaram, M., Nabower, A. M., Rajbhandari, P., Eisenberg, J., Goodrich, N. P., Ampofo, K., Gollehon, N. S., Martin, K., Lyden, E. R., & Snowden, J. N. (2022) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piab126 · Cited by 16
Huang, J., Zhong, Y., Li, W., Wang, W., Li, C., Wang, A., Yan, H. G., Wan, Y., & Li, J. (2020) · ACS Sensors · doi:10.1021/acssensors.0c02007 · Cited by 16
Erba, A., Franzeck, F. C., Hinic, V., Egli, A., & Osthoff, M. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1351903 · Cited by 15
“Although many institutions are already using it and several studies anticipate a benefit for clinical and antimicrobial stewardship outcomes (5, 10), the risk of overutilization as well as false-positive results reported in the literature, call for a more careful and evidence-based approach to this…”
BackgroundMethodInfluentialCredle, J. J., Robinson, M. L., Gunn, J., Monaco, D. R., Sie, B. M., Tchir, A., Hardick, J. P., Zheng, X. A., Shaw‐Saliba, K., Rothman, R. E., et al. (2021) · Modern Pathology · doi:10.1038/s41379-020-00730-5 · Cited by 14
Kardjadj, M. (2025) · The Journal of Applied Laboratory Medicine · doi:10.1093/jalm/jfaf106 · Cited by 15
Pathogen and Antibody Identification in Children with Encephalitis in Myanmar
Galardi, M. M., Sowa, G. M., Crockett, C. D., Rudock, R., Smith, A. E., Shwe, E. E., San, T., Linn, K., Aye, A. M. M., Ramachandran, P. S., et al. (2023) · Annals of Neurology · doi:10.1002/ana.26560 · Cited by 14
Olarte, L., & Jackson, M. A. (2021) · Pediatrics in Review · doi:10.1542/pir.2020-0062 · Cited by 14
Mostyn, A., Lenihan, M., O’Sullivan, D. M., Woods, S., O'Hara, M., Powell, J., Power, L., O’Connell, N. H., & Dunne, C. P. (2020) · Infection Prevention in Practice · doi:10.1016/j.infpip.2020.100042 · Cited by 24
“The manufacturer of the BioFire FilmArray MEP state that the limit of detection (LOD) is 100e1,000 CFU/ml for all bacteria & yeast, and 5e500 Tissue Culture Infective Dose (TCID) 50/ml or 100e1,000 copies/ml for all viruses, which was utilised as the LOD for this study [11].”
MethodDiaz, K. M. O., Piedrahíta, J. A. A., Suárez-Brochero, Ó. F., Granada, D. O., Barón, L. M., Cortés-Bonilla, I., & Hasbun, R. (2020) · Epidemiology and Infection · doi:10.1017/s0950268820001648 · Cited by 17
Greninger, A. L., Naccache, S. N., Pannaraj, P., Jerome, K. R., Dien Bard, J., & Ruderman, J. W. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.02016-18 · Cited by 13
“HHV-6 is revealed to be the second most commonly detected target in evaluation studies of the FilmArray M/E panel after enteroviruses (9).”
BackgroundUse of a Molecular Panel To Aid in Diagnosis of Culture-Negative Meningitis
Bard, J. D., Naccache, S. N., & Bender, J. M. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.01957-16 · Cited by 14
“gal) and the potential for a 1-h sample-to-answer turnaround time (4, 5).”
BackgroundAbbott, A. N., & Fang, F. C. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.08.004 · Cited by 13
Wagner, K., Springer, B., Pires, V. P., & Keller, P. M. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.11.006 · Cited by 14
“Recently, many syndromic point-of-care tests were launched that enable the detection of a panel of viral, bacterial, and fungal pathogens (Buss et al., 2015; Leber et al., 2016; Popowitch et al., 2013).”
BackgroundZida, S., Kolia-Diafouka, P., Kania, D., Sotto, A., Foulongne, V., Bolloré, K., Ouangraoua, S., Méda, N., Carrère‐Kremer, S., de Perre, P. V., et al. (2018) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22719 · Cited by 16
Rafiei, N., Subedi, S., Harris, P. N., & Paterson, D. L. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.116823 · Cited by 13
Molecular Diagnostic Advances in Transplant Infectious Diseases
Young, B. A., Hanson, K. E., & Gómez, C. A. (2019) · Current Infectious Disease Reports · doi:10.1007/s11908-019-0704-7 · Cited by 16
Molecular and Histologic Diagnosis of Central Nervous System Infections
Solomon, I. H. (2020) · Surgical pathology clinics · doi:10.1016/j.path.2020.01.001 · Cited by 12
Ramachandran, P., & Grose, C. F. (2024) · Reviews in Medical Virology · doi:10.1002/rmv.2538 · Cited by 14
“48 Besides VZV, the Biofire panel contains primers for 13 other pathogens: HSV 1).”
BackgroundCamprubí-Ferrer, D., Cobuccio, L. G., Broucke, S. V. D., et al. (2023) · Journal of Travel Medicine · doi:10.1093/jtm/taad041 · Cited by 13
Blood PCR testing for enteroviruses in young children
Messacar, K., & Dominguez, S. R. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30492-4 · Cited by 12
Boers, S. A., van Houdt, R., van Sorge, N. M., Groot, J., van Aarle, Y., van Bussel, M. J. A. W. M., Smit, L. F. E., Wessels, E., & Claas, E. C. J. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04751-9 · Cited by 12
“Where the FA-ME has been around for many years [2], the QS-ME has been launched only recently.”
BackgroundMyint, T., Soria, J., Gao, Y., Conejo Castillo, M. R., Arora, V., & Ribes, J. A. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.00014-24 · Cited by 12
Crosstalk Between Covid-19 and Associated Neurological Disorders: A Review
Ramachandran, A. K., Das, S., & Joseph, A. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210113154342 · Cited by 12
Otake, S., Nakagawa, Y., Ryu, H., Oue, T., & Kasai, M. (2022) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2022.05.005 · Cited by 12
Kommedal, Ø., Eagan, T., Fløtten, Ø., Leegaard, T. M., Siljan, W. W., Fardal, H., Bø, B., Grøvan, F., Larssen, K. W., Kildahl-Andersen, A., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.03510-23 · Cited by 13
Ren, X., Yue, X., Mwakinyali, S. E., Zhang, W., Zhang, Q., & Li, P. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.03023 · Cited by 12
Ngo Nsoga, M. T., Pérez-Rodriguez, F. J., Mamin, A., L’Huillier, A. G., Cherkaoui, A., Kaiser, L., & Schibler, M. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.03179-22 · Cited by 11
Walker, M., Taylor, K., Beaulieu, R., Laurent, M., Hamer, D., & O'Neal, C. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.09.020 · Cited by 11
The neuropathological impact of COVID-19: a review
Fouad, G. I. (2021) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-020-00478-7 · Cited by 11
McCreery, R., Nielsen, L., Clarey, D., Murphy, C., & Van Schooneveld, T. C. (2022) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2021.115605 · Cited by 11
Expanding Molecular Diagnostics for Central Nervous System Infections
Gutierrez, M., & Emmanuel, P. J. (2018) · Advances in Pediatrics · doi:10.1016/j.yapd.2018.04.005 · Cited by 11
Launes, C., Camacho, J., Pons‐Espinal, M., López‐Labrador, F. X., Esteva, C., Cabrerizo, M., Fernández-García, M. D., Fogeda, M., Calles, J. M., López-Perea, N., et al. (2024) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-024-04795-x · Cited by 12
Jiang, H., Xing, Z., Liu, X., Chai, Q., Xin, Z., Zhu, C., Lin, R., Deng, X., Dong, C., Gao, H., et al. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07272-y · Cited by 14
“Bacteria include Streptococcus pneumoniae, Escherichia coli, Streptococcus agalactiae, Haemophilus influenzae, and Neisseria meningitides [3, 4].”
BackgroundSorek, N., Ashkenazi, S., Livni, G., & Ben‐Zvi, H. (2019) · IDCases · doi:10.1016/j.idcr.2019.e00516 · Cited by 12
“8% (95% CI), false positive for CMV detection in the filmarray meningitis/encephalitis test has been reported [9].”
BackgroundSunnerhagen, T., Widén, J., Handhal, S., & Şahin, G. Ö. (2024) · Scientific Reports · doi:10.1038/s41598-024-54621-9 · Cited by 16
Milburn, J., Suresh, R., Doyle, R., & Jarvis, J. N. (2024) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2024.2317414 · Cited by 12
Subedi, S., Harris, P. N. A., Hall, L., & Paterson, D. L. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.06.013 · Cited by 15
Long, F., Kong, M., Wu, S., Zhang, W., Liao, Q., Peng, Z., Li, N., Liu, Y., Wang, M., He, C. S., et al. (2019) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.22707 · Cited by 15
Pence, M. A., & Liesman, R. M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815499-1.00055-7 · Cited by 15
Hara, M., Ishihara, M., & Nakajima, H. (2022) · Journal of International Medical Research · doi:10.1177/03000605221129561 · Cited by 10
“neoformans/gattii.(3,9,15) If there is a high index of clinical suspicion for herpes simplex encephalitis despite a negative result on the FilmArrayR ME panel, additional testing using qRT-PCR should be performed.”
MethodResultDelirium in Meningitis and Encephalitis: Emergence and Prediction in a 6-Year Cohort
Dittrich, T. D., Marsch, S. C. U., Rüegg, S. J., Marchis, G. M. D., Tschudin‐Sutter, S., & Sutter, R. (2020) · Journal of Intensive Care Medicine · doi:10.1177/0885066620913004 · Cited by 12
Olson, C. A., Dominguez, S. R., Miller, S. A., Chiu, C. Y., & Messacar, K. (2019) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2019.04.058 · Cited by 10
“7 Multiplexed testing has the potential to identify a broader clinical spectrum of acute infection in immunocompetent children, as testing for HHV-6 alone is rarely pursued.”
Background(2020) · doi:10.1016/j.jmii.2020.05.012 · Cited by 10
“Therefore, mPCR is used for the diagnosis of many infectious diseases including respiratory infectious disease, infectious gastroenteritis,(11) and infections of the central nervous system such as meningitis and encephalitis.(12) This study was conducted retrospectively to investigate the effectiveness of mPCR for the…”
D’Inzeo, T., Menchinelli, G., Angelis, G. D., Fiori, B., Liotti, F. M., Morandotti, G. A., Sanguinetti, M., Posteraro, B., & Spanu, T. (2020) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-03909-5 · Cited by 12
“One of these assays, namely the FilmArray ME (BioMérieux, France, previously BioFire Diagnostics, USA) panel, has been USA Food and Drug Administration approved to allow the simultaneous detection of 14 different viral, bacterial, or yeast targets in CSF samples [20].”
MethodBouam, A., Vincent, J.-J., Drancourt, M., Raoult, D., & Levy, P. (2020) · Letters in Applied Microbiology · doi:10.1111/lam.13375 · Cited by 12
“Multiplexed real-time PCR assays allow for the simultaneous detection and quantification of several pathogens in the same clinical specimen in one experiment, allowing a syndrome-based diagnosis (Blaschke et al. 2012; Leber et al. 2016; Drancourt et al. 2016; Liesman et al. 2018).”
BackgroundMethodResultInfluential[Meningitis/Encephalitis diagnosis in ICU using Multiplex PCR system: Is it time of change?]
López-Amor, L., Escudero, D., Fernández, J., Martín-Iglesias, L., Viña, L., Fernández-Suárez, J., Leal-Negredo, Á., Leoz, B., Álvarez-García, L., Castelló-Abiétar, C., et al. (2019) · Europe PMC (PubMed Central) · Cited by 10
Mizusawa, M., & Carroll, K. C. (2023) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2023.2234823 · Cited by 11
Self-citationRichards, R. J., Simon, M. S., Phillips, C. D., Lief, L., Jenkins, S. G., & Satlin, M. S. (2018) · BMJ Case Reports · doi:10.1136/bcr-2018-225575 · Cited by 11
Kadambari, S., Feng, S., Liu, X., Andersson, M. I., Waterfield, R., Fodder, H., Jacquemot, A., Galal, U., Rafferty, A., Drew, R. J., et al. (2024) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000004236 · Cited by 12
Preterm and Term Infants Evaluated for Sepsis: Differences in Management and Clinical Outcomes
Marsh, M. C., Lin, H. M., Black, J., Allen, K., Weiner, B., Ramilo, O., Klamer, B. G., Watson, J. R., & Kasick, R. T. (2023) · Hospital Pediatrics · doi:10.1542/hpeds.2022-007050 · Cited by 11
Development of a Mobile Laboratory for Sudden Onset Disasters
Marr, I., Francis, J., Stephens, D., Marshall, K., Read, D. J., Baird, R., & Coatsworth, N. (2020) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2019.128 · Cited by 4
Métodos de diagnóstico rápido de las infecciones respiratorias
Marimón, J. M., & Navarro‐Marí, J. M. (2017) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2016.11.007 · Cited by 11
“Además del diagnóstico de la neumonía, los TDR de neumococo también se han utilizado para la detección del patógeno en muestras estériles como el LCR en las meningitis 26, 27 o el líquido pleural en derrames paraneumónicos 28 .”
BackgroundKampouri, E., Handley, G. H., Phan, T. L., Lee, Y. J., Shaw, R. B., Carpenter, P. A., Dadwal, S., Chemaly, R. F., Papanicolaou, G. A., Ogata, M., et al. (2025) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2025.05.001 · Cited by 15
Ena, J., Afonso-Carrillo, R. G., Bou-Collado, M., Reyes-Jara, M. D., Navarro‐Soler, R., de Haedo-Sanchez, D., Martinez-Peinado, C., Gómez-Alonso, B., & Arjona-Zaragozí, F. J. (2021) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02593-9 · Cited by 10
“Studies evaluating the sensitivity and specificity of FilmArray ME panel compared to other reference methods, such as conventional culture and identification using MALDI-TOF (matrix-assisted laser desorption/ionization associated with coupled ion detector), and other PCR techniques ( polymerase chain reaction) for vir…”
BackgroundMethodBedoya, C. A. P., Mesa, S. E., Leal, A., Castaño, T., Bustamante, J., & Ospina, S. (2020) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946202062077 · Cited by 31
Diagnosis and Treatment of Fungal Infections in Lung Transplant Recipients
Escamilla, J. E., January, S. E., & Guillamet, R. V. (2023) · Pathogens · doi:10.3390/pathogens12050694 · Cited by 10
Bhutda, S., Ghosh, S., Sinha, A. R., Santra, S., Hiray, A., & Banerjee, A. (2021) · Journal of Bacteriology · doi:10.1128/jb.00456-21 · Cited by 6
“Due to all these factors, regardless of advances in antibiotic therapy and vaccines, bacterial meningitis still remains a burning global health issue with a high rate of morbidity and mortality (7).”
BackgroundMilburn, J., Lechiile, K., Siamisang, K., Williams, C. G., Owen, L., Gwakuba, E., Machiya, T., Leeme, T., Barton, H. E., Doyle, R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac229 · Cited by 12
Direct Metagenomic Diagnosis of Community-Acquired Meningitis: State of the Art
Morsli, M., Lavigne, J.-P., & Drancourt, M. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.926240 · Cited by 10
“Community-acquired meningitis (CAM), a life-threatening condition with 40% mortality (Beaman, 2018), warrants a rapid diagnosis, possibly within 2 h at a point-of-care (POC) laboratory, providing identification of the causative pathogen among a repertoire of fewer than 20 pathogens (Leber et al., 2016; Launes et al.,…”
BackgroundSmith, H. Z., Paguia, R., Horne, J., & Velagapudi, M. (2019) · Cureus · doi:10.7759/cureus.4636 · Cited by 9
“When the discrepancy of false positivity is investigated though, the rate of false positivity for HHV-6 increased to 75% [16].”
BackgroundVölk, S., Dobler, F., Koedel, U., Pfister, H., Bruegel, M., Schubert, S., & Klein, M. (2022) · European Journal of Neurology · doi:10.1111/ene.15638 · Cited by 10
“The BioFire FilmArray® is a ME panel which covers 14 pathogens that commonly cause CNS infections, including six bacteria (Escherichia coli K1, Haemophilus influenzae, Listeria monocytogenes, Neisseria meningitidis, Streptococcus agalactiae and Streptococcus pneumoniae), seven viruses (cytomegalovirus [CMV], EV, HSV t…”
BackgroundResultInfluentialSullivan, K. V. (2017) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2017.08.001 · Cited by 9
“pneumoniae from CSF in culture-negative cases that were confirmed using another arbiter PCR assay [27].”
Antimicrobial Stewardship Program in Critical Care—Need of the Hour
Vadala, R., & Princess, I. (2020) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23557 · Cited by 10
Improved Diagnostics in Bacterial Neonatal Meningitis Using a Next-Generation Sequencing Platform
van der Hoeven, A., van der Beek, M. T., Bekker, V., Meijers, E., Ivens, M. J. R., Wessels, E., Kroes, A. C. M., & Boers, S. A. (2023) · Infectious Diseases and Therapy · doi:10.1007/s40121-023-00844-8 · Cited by 8
“meningitis multiplex PCR panels, which also have the advantage of having short processing times [5].”
BackgroundBerkhout, A., Cheng, D. R., McNab, S., Lee, L., Daley, A. J., & Clifford, V. (2022) · The Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003812 · Cited by 9
Impact of CSF Meningitis and Encephalitis Panel on Resource Use for Febrile Well-Appearing Infants
DesPain, A. W., Pearman, R., Hamdy, R. F., Campos, J. M., Badolato, G. M., & Breslin, K. A. (2022) · Hospital Pediatrics · doi:10.1542/hpeds.2021-006433 · Cited by 7
Rasti, R., Kumbakumba, E., Nanjebe, D., Mlotshwa, P., Nassejje, M., Mzee, J., Businge, S., Akankwasa, G., Nyehangane, D., Gantelius, J., et al. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10732-w · Cited by 8
“1) in minimal CSF volumes, offering reduced turnaround time and high diagnostic accuracy [1, 3, 17–19].”
Clinical utility of pan-microbial PCR assays in the routine diagnosis of infectious diseases
Khoury, N., Amit, S., Geffen, Y., & Adler, A. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.09.016 · Cited by 8
Pilmis, B., Bougnoux, M., Guéry, R., Senghor, Y., Monnier, A. L., Lanternier, F., Bretagne, S., Alanio, A., & Lortholary, O. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13263 · Cited by 9
“In a multicenter evaluation on the sensitivity and specificity of the FilmArray ME panel of 1560 cerebrospinal fluid (CSF) specimens, no false negatives were reported.[11] This study included only 5 cryptococcal infections.”
BackgroundApproach to Neurologic Infections
Berkowitz, A. L. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000984 · Cited by 16
Guo, L., Qiu, Z., Wang, Y., Yu, K., Zheng, X., Li, Y., Liu, M., Wang, G., Guo, N., Yang, M., et al. (2021) · European Neurology · doi:10.1159/000507188 · Cited by 8
Cheng, H. K.-H., Tan, S. K., Sweeney, T. E., Jeganathan, P., Briese, T., Khadka, V. D., Strouts, F. R., Thair, S. A., Dalai, S. C., Hitchcock, M. M., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/854182 · Cited by 7
Chen, X., Guo, J., Li, J., Li, Q., Ai, J., Sun, S., & Xie, Z. (2018) · Pediatric Investigation · doi:10.1002/ped4.12037 · Cited by 9
Lin, G. Y.-E., Lin, C., Chi, H., Huang, D. T., Huang, C., & Chiu, N. (2022) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2022.07.013 · Cited by 9
Guerrero, M. P., Romero, A. F., Luengas, M., Dávalos, D. M., Mesa-Monsalve, J. G., Vivas-Trochez, R., Camacho-Moreno, G., Trujillo-Valencia, M., Giraldo, J. P. C., Mejía, L. F., et al. (2022) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0000000000003637 · Cited by 8
“High positive and negative agreements between the FA ME and conventional techniques have been reported.(11,12)”
BackgroundMolecular assays for the diagnosis of sepsis in neonates: a diagnostic test accuracy review
Dierikx, T. H., Visser, D. H., de Meij, T. G. J., Versalovic, J. A., Leeflang, M., Cooper, C., & Pammi, M. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011926.pub3 · Cited by 23
Diagnostic Value of Thromboelastography (TEG) for the Diagnosis of Death in Infected Patients
Xuan, J., Wang, J., & Wei, B. (2021) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296211047231 · Cited by 7
Mpox and Viral Co‐Infections: A Narrative Review
(2025) · doi:10.1002/hsr2.70464 · Cited by 7
“Moreover, the use of swabs collected in universal transport media (UTM) for Mpox testing can be easily integrated with the BioFire ME panel, streamlining the diagnostic process for viral exanthems in patients being evaluated for Mpox infection [58 – 60].”
COVID-19 and its impact on the brain and Mind- A conceptual model and supporting evidence
Saeed, S. A., Pastis, I., & Santos, M. G. (2022) · Psychiatric Quarterly · doi:10.1007/s11126-022-09980-9 · Cited by 9
“Studies have shown that the genetic material and protein of viruses can be detected in CNS samples indicating direct CNS invasion and neuronal tissue damage [10], [11].”
BackgroundEvaluation and Management of Young Febrile Infants: An Overview of the New AAP Guideline
Leazer, R. C. (2023) · Pediatrics in Review · doi:10.1542/pir.2022-005624 · Cited by 10
Alignment of Fellowship Training with Practice Patterns for Molecular Pathologists
Velu, P., Cushman‐Vokoun, A. M., Ewalt, M. D., Feilotter, H. E., Gastier, J. M., Goswami, R. S., Laudadio, J., Olsen, R. J., Johnson, R., Schlinsog, A., et al. (2022) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2022.04.011 · Cited by 7
Rapid Diagnostics and Biomarkers for Antimicrobial Stewardship
Pardo, J. R. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-810477-4.00006-4 · Cited by 7
Cobo, F., Borrego, J. J., Rodríguez‐Granger, J., Puertas, A., Sampedro, A., & Navarro‐Marí, J. M. (2019) · PubMed Central · Cited by 7
Opinion on Syndromic Panel-Based Testing in Clinical Microbiology
Miller, M. B. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2019.304832 · Cited by 6
Li, Z., Tan, L., Zhang, J., Long, Q., Chen, Z., Xiang, Z., Wu, W., Guo, Z., Liu, H., Hu, B., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1463081 · Cited by 12
Infectious causes and outcomes in patients presenting with cerebral spinal fluid pleocytosis
Brown, B., Fidell, A., Ingolia, G., Murad, E., & Beckham, J. D. (2019) · Journal of NeuroVirology · doi:10.1007/s13365-019-00739-w · Cited by 6
Epidemiology of pediatric meningitis and encephalitis in Japan: a cross-sectional study
Mizuno, S., Kusama, Y., Otake, S., Ito, Y., Nozaki, M., & Kasai, M. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.01192-24 · Cited by 6
Gaensbauer, J. T., Fernholz, E., Hiskey, L., Binnicker, M. J., & Campioli, C. C. (2023) · Journal of Clinical Virology · doi:10.1016/j.jcv.2023.105528 · Cited by 6
Syndromic and Point-of-Care Molecular Testing
Relich, R. F., & Abbott, A. N. (2022) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.09.008 · Cited by 9
Ocampo, F. F., Espiritu, A. I., & Jamora, R. D. G. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13704 · Cited by 8
“When the CSF culture is negative, additional diagnostic tests such as Gram staining, latex agglutination, blood cultures, bacterial antigen tests and polymerase chainbased molecular tests such as the FilmArrayTM Meningitis/ Encephalitis panel [42] may provide additional valuable information.”
MethodGeteneh, A., Kassa, T., Alemu, D., Kiros, M., Henok, A., Tenna, A., Tesfaye, A., Alemayehu, D. H., Mihret, A., Howe, R., et al. (2021) · Infection and Drug Resistance · doi:10.2147/idr.s304521 · Cited by 7
Greninger, A. L., Naccache, S. N., Pannaraj, P. S., Jerome, K. R., Bard, J. D., & Ruderman, J. W. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.02018-18 · Cited by 6
Etiological Analysis of Viral Encephalitis in Children in Zhejiang Province from 2018 to 2019
Liu, J., Teng, L.-P., Hua, C., Xie, Y.-P., Pan, Y., Hu, B.-F., Hu, W., & Wang, W. (2022) · Diagnostics · doi:10.3390/diagnostics12081964 · Cited by 9
“A rapid, sensitive, and comprehensive test for the common infectious encephalitis pathogens requiring only a small amount of CSF would be very useful [10].”
Background
Metadata
- Authors
- Leber, A. L., Everhart, K., Balada-Llasat, J.-M., Cullison, J., Daly, J., Holt, S., Lephart, P., Salimnia, H., Schreckenberger, P. C., DesJarlais, S., Reed, S. L., Chapin, K. C., LeBlanc, L., Johnson, J. K., Soliven, N. L., Carroll, K. C., Miller, J.-A., Dien Bard, J., Mestas, J., Bankowski, M., Enomoto, T., Hemmert, A. C., & Bourzac, K. M.
- Affiliations
- Nationwide Children's Hospital (US)
- The Ohio State University Wexner Medical Center (US)
- Primary Children's Hospital (US)
- Detroit Medical Center (US)
- Loyola University Medical Center (US)
- University of California San Diego (US)
- Rhode Island Hospital (US)
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Johns Hopkins Hospital (US)
- Children's Hospital Los Angeles, Los Angeles, California, USA
- Children's Hospital Los Angeles (US)
- University of Hawaiʻi at Mānoa (US)
- Diagnostic Laboratory Services (The Queen's Medical Center), Aiea, Hawaii, USA
- BioFire Diagnostics (United States) (US)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2016-09
- Volume
- 54
- Issue
- 9
- Pages
- 2251-2261
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC5005480
- OpenAlex
- W2460625652
- Cited by
- 609
- References
- 54
- Citations by year
- 2026: 40 · 2025: 59 · 2024: 48 · 2023: 61 · 2022: 62 · 2021: 68 · 2020: 92 · 2019: 75 · 2018: 59 · 2017: 31 · 2016: 14
- FWCI
- 58.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
- Health Sciences › Medicine › Infectious Diseases › Infectious Encephalopathies and Encephalitis
- Keywords
- FilmArray Meningitis/Encephalitis panel, infectious meningitis, encephalitis, cerebrospinal fluid, multiplex PCR, pathogen detection, sensitivity and specificity, Neisseria meningitidis, Streptococcus agalactiae, herpes simplex virus, cytomegalovirus, Cryptococcus neoformans, Listeria monocytogenes, Escherichia coli K1, Haemophilus influenzae, varicella-zoster virus, human herpesvirus 6, enterovirus, antimicrobial stewardship
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Bacteria, Bacterial Infections, Cerebrospinal Fluid, Child, Child, Preschool, Encephalitis, Female, Fungi, Humans, Infant, Infant, Newborn, Male, Meningitis, Middle Aged, Prospective Studies, Sensitivity and Specificity, Time Factors, Virus Diseases, Viruses, Central Nervous System Fungal Infections, Molecular Diagnostic Techniques, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.